Medable
Medable offers a digital clinical trial platform that enhances the efficiency of clinical trials across various therapeutic areas, including Oncology and Vaccine development, and is compliant with major global regulations.
Medable Digital Clinical Trial Platform
Medable offers a comprehensive digital clinical trial platform aimed at simplifying and accelerating the clinical trial process. Designed to support a variety of therapeutic areas such as Oncology and Vaccine development, the platform is equipped with advanced features like eConsent, TeleVisit, eCOA, and remote monitoring. These functionalities ensure that clinical trials can be efficiently managed and conducted, meeting the needs of mid to large pharmaceutical companies, emerging biopharma, and contract research organizations (CROs).
Medable Solutions for Oncology and Vaccine Development
Medable provides targeted solutions for specific therapeutic areas, including Oncology and Vaccine development. These tailored solutions are designed to address the unique challenges associated with each therapeutic area, offering specialized tools and resources that facilitate streamlined clinical trials. By focusing on these crucial areas of research, Medable aims to advance the development of critical treatments and vaccines efficiently.
Global Reach and Compliance of Medable Platform
The Medable platform is internationally recognized, supporting clinical trials in over 60 countries and available in more than 120 languages. It complies with key global regulations, including FDA 21 CFR Part 11, HIPAA, and GDPR, ensuring that the platform meets stringent data privacy and security standards. This global compliance allows pharmaceutical companies and CROs to conduct clinical trials confidently and in accordance with regulatory requirements across different regions.
Successful eConsent Adoption in U.S. Renal Care Clinical Trial
Medable achieved significant success in achieving 75% eConsent adoption among elderly patients in a U.S. Renal Care clinical trial. This milestone underscores the platform's user-friendly design and its capability to improve patient engagement and consent processes, even among populations that may be less familiar with digital technologies. This success demonstrates Medable's effectiveness in enhancing clinical trial execution and patient experience.
Prix Galien Award for Best Digital Health Solution 2023
In 2023, Medable was honored with the Prix Galien Award for Best Digital Health Solution, recognizing its innovative contributions to the field of digital health. This prestigious award highlights the platform's excellence in providing cutting-edge tools that transform how clinical trials are conducted, making Medable a key player in the digital health landscape.